STAT3 and liver cancer: STAT3 decoy ODN inhibited hepatic cancer cell proliferation in a dose-dependent manner, and the inhibitory effect was significant at a concentration of 500 nM in HuH-7 cells and 1000 nM in HepG2 cells when compared to the maximum concentration of Lipofectamine (p < 0.01; Figure 1b).